HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen

• P. Gantner,
• M. Partisani,
• C. Barnig,
• G. Beck-Wirth,
• J.P. Faller,
• M. Artinot,
• M. Mohseni-Zadeh,
• C. Cheneau,
• M.L. Batard,
• A. Fuchs,
• P. Fischer,
• S. Bahram,
• D. Rey,
• S. Fafi-Kremer

Affiliations

P. Gantner

Strasbourg University, INSERM, UMR-S 1109, Strasbourg, France

M. Partisani

Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France

C. Barnig

Physiology and functional explorations department, Strasbourg University Hospital, Strasbourg, France

G. Beck-Wirth

Internal Medicine Department, HIV-infection care center, Groupe Hospitalier Regional-Mulhouse Sud Alsace, Mulhouse, France

J.P. Faller

Department of Infectious Diseases, Hôpital Nord Franche Comté, Belfort, France

M. Artinot

Internal Medicine and Rheumatology Department, Hôpital Civil de Colmar, Colmar, France

M. Mohseni-Zadeh

Internal Medicine and Rheumatology Department, Hôpital Civil de Colmar, Colmar, France

C. Cheneau

Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France

M.L. Batard

Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France

A. Fuchs

Virology laboratory, Strasbourg University Hospital, Strasbourg, France

P. Fischer

Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France

S. Bahram

Strasbourg University, INSERM, UMR-S 1109, Strasbourg, France

D. Rey

Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France

S. Fafi-Kremer

Virology laboratory, Strasbourg University Hospital, Strasbourg, France; Strasbourg University, INSERM, UMR-S 1109, Strasbourg, France